Fully autonomous reporting of normal chest X-rays (excludes them from radiologist review entirely).
CE marked as the first entirely autonomous medical imaging AI certified in Europe.
Acquirer’s (Sectra) own press release.
Acquisition by Sectra (a public, independent PACS vendor) is independently verifiable as a signal of commercial maturity, though not itself a clinical-outcomes study.
Acquisition by Sectra in 2026 confirms commercial maturity; exact site count not found in this pass.
As a fully autonomous tool (no radiologist second read for cases it clears), the clinical governance model differs fundamentally from adjunct tools — flag this explicitly on the public profile.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.